Hot or Not, Stock Market Edition: 10/07/2025
Happy Tuesday. We’ve got a special treat today: 3 hot stocks … and one that’s not. Are you holding any of ‘em?
- Hot: Not 2 but 3 picks today: Amphenol Corporation (APH) has momentum, Micron Technology (MU) heats up, and Danaher (DHR) has a moment
- Not: Just one stock on the naughty list today — Toronto-Dominion Bank (TD). Keep reading to see why it’s flashing warning signs.
P.S. For more stocks making moves, check out our Zen Ratings Upgrades & Downgrades screener.
A note from our sponsors...
Here's the Best Day to Buy Stocks Did you know the S&P 500 has a 100% history of soaring, beginning on one particular day every fall? We call this the "Green Day phenomenon." It works on 5,000 stocks. For example, Nvidia has a 100% history of soaring beginning on one particular day every single year. Click here to see the green days for 7 major stocks today.🔥 HOT: Amphenol Corporation (APH) is hitting all the right notes for momentum. This electronic component juggernaut is up a staggering 96% in the past year. Why? APH just keeps posting strong earnings, getting repeated buy recommendations from heavyweight banks, and landing in every smart investor’s dividend-growth list. It’s a favorite of analysts and TV pundits alike (even Jim Cramer called it "a rocket ship" — take that as you will). With a Zen Rating in the top 92nd percentile, Amphenol clinches a B overall but knocks it out of the park with an A in Momentum and a B in Growth and Financials. The industry context could hardly be stronger—strong earnings momentum and expansion into new growth verticals have Amphenol galloping ahead of the pack. Verdict: Buy. The steady uptrend and momentum stamp make this one hard to ignore for the long haul.
🔥 HOT: Danaher (DHR) has snapped out of its midyear slumber, surging as much as 7% and suddenly hogging the health care limelight. The life sciences innovator scored big on Wall Street optimism after unveiling AI-powered digital pathology solutions—think next-generation diagnostics—and benefited from news of upcoming pharma tariffs poised to pad its margins. Throw in a recent analyst note touting Danaher’s undervaluation and a Q3 earnings report on deck after beating Street expectations last quarter, and investors are clearly sniffing out more upside. With a Zen Rating of 81.2 and a steady B Grade, Danaher’s firmly planted in the market’s top tier, even as most Component Grades hover at C (no Fs to be found here). Its diversified Diagnostic & Research business keeps it resilient, and while its Value and Growth Grades are both C, the stock’s appeal comes from its knack for innovation and an industry position ranked 9th out of 47. The price is now at $214.99—well above short-term moving averages, signaling a return of bullish momentum despite so-so component scores and a generally average sector rating. Big verdict: Buy—innovation tailwinds and a bullish narrative around AI diagnostics make Danaher too hot to ignore.
🔥 HOT: Micron Technology (MU) has surged a jaw-dropping 45% in the past month, thanks to this triple threat: 1) Booming demand for AI infrastructure 2) Recently-reported record revenues 3) A fresh dividend boost. Micron was recently upgraded from a Zen Rating of B (Buy) to our highest rating — A (Strong Buy). Standout Component Grades shaping the overall rating demonstrate particular strength in Value, Momentum, and Financials (all B, or above-average, ratings). Considering its excellent rating and AI's ability to move markets and stocks for the foreseeable future, MU still looks like it’s got plenty of headroom.
🥶 NOT: Toronto-Dominion Bank (TD) is trying to make lemonade in a distinctly lemony industry (Diversified Banks have an Industry Rating of F right now in our Zen Ratings system — here's why that matters). Yet despite 8% gains in the past month as a result of restored financial targets, billions in shareholder returns, and slashed costs thanks to AI, it's rated D (Sell) according to our 115-factor quant ratings system. Growth and Value Grades are C and D, and Financials barely scrape a C, hardly inspiring confidence. Despite a few recent analyst upgrades, Smart Money seems so-so on this stock, and the macro picture for banks remains cloudy.
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.